Gabriel S. Panayi
London, ENG SE11UL, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
The Biologic IRL201805 Alters Immune Tolerance Leading to Prolonged Pharmacodynamics and Efficacy in Rheumatoid Arthritis Patients.
Journal: International journal of molecular sciences
Published: March 06, 2024
Binding Immunoglobulin Protein (BIP) Inhibits TNF-α-Induced Osteoclast Differentiation and Systemic Bone Loss in an Erosive Arthritis Model.
Journal: ACR open rheumatology
Published: February 15, 2019
The frequency of remission and low disease activity in patients with rheumatoid arthritis, and their ability to identify people with low disability and normal quality of life.
Journal: Seminars in arthritis and rheumatism
Published: September 09, 2018
Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis.
Journal: BMC rheumatology
Published: August 06, 2018
Safety and patient response as indicated by biomarker changes to binding immunoglobulin protein in the phase I/IIA RAGULA clinical trial in rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: October 19, 2015
Immunoglobulin heavy-chain-binding protein (BiP): a stress protein that has the potential to be a novel therapy for rheumatoid arthritis.
Journal: Biochemical Society transactions
Published: November 18, 2014
Systemic gene transfer of binding immunoglobulin protein (BiP) prevents disease progression in murine collagen-induced arthritis.
Journal: Clinical and experimental immunology
Published: August 26, 2014
Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis.
Journal: Arthritis and rheumatism
Published: August 01, 2012
Goal-directed therapy for RA in routine practice is associated with improved function in patients with disease duration up to 15 years.
Journal: Rheumatology (Oxford, England)
Published: January 07, 2012
Pro-resolution immunological networks: binding immunoglobulin protein and other resolution-associated molecular patterns.
Journal: Rheumatology (Oxford, England)
Published: December 23, 2011
A New-Age for Biologic Therapies: Long-Term Drug-Free Therapy with BiP?
Journal: Frontiers in immunology
Published: December 10, 2011
BiP regulates autoimmune inflammation and tissue damage.
Journal: Autoimmunity reviews
Published: January 25, 2006
Last Updated: 09/26/2026